Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study

We aimed to investigate vaccine effectiveness against progression to severe COVID-19 (acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission and/or death) and in-hospital death in a cohort of hospitalized COVID-19 patients. Mixed effects logistic regression analyses were performed to estimate the association between receiving a primary COVID-19 vaccination schedule and severe outcomes after adjusting for patient, hospital, and vaccination characteristics. Additionally, the effects of the vaccine brands including mRNA vaccines mRNA-1273 and BNT162b2, and adenovirus-vect... Mehr ...

Verfasser: Queeny Robalo
Laurane De Mot
Mathil Vandromme
Nina Van Goethem
Andrea Gabrio
Pui Yan Jenny Chung
Marjan Meurisse
Lucy Catteau
Carel Thijs
Koen Blot
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Vaccines, Vol 11, Iss 14, p 14 (2022)
Verlag/Hrsg.: MDPI AG
Schlagwörter: SARS-CoV-2 / COVID-19 / Delta / hospitalized / vaccine / brand / Medicine / R
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26924605
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/vaccines11010014